Chair: Jarad Martin
Case 1: Localised prostate cancer - who should we treat and how
Case 2: Optimal management of the lymph nodes in high risk prostate cancer
Case 3: New treatment paradigms in metastatic disease
Chair: Jarad Martin
Case 1: Localised prostate cancer - who should we treat and how
Case 2: Optimal management of the lymph nodes in high risk prostate cancer
Case 3: New treatment paradigms in metastatic disease